000 01475 a2200445 4500
005 20250513201335.0
264 0 _c20000224
008 200002s 0 0 eng d
022 _a0091-2700
024 7 _a10.1177/00912700022008595
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGoldberg, M R
245 0 0 _aRizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjects.
_h[electronic resource]
260 _bJournal of clinical pharmacology
_cJan 2000
300 _a74-83 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article
650 0 4 _aAdult
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPlacebos
650 0 4 _aSerotonin Receptor Agonists
_xadministration & dosage
650 0 4 _aTime Factors
650 0 4 _aTriazoles
_xadministration & dosage
650 0 4 _aTryptamines
700 1 _aLee, Y
700 1 _aVyas, K P
700 1 _aSlaughter, D E
700 1 _aPanebianco, D
700 1 _aErmlich, S J
700 1 _aShadle, C R
700 1 _aBrucker, M J
700 1 _aMcLoughlin, D A
700 1 _aOlah, T V
773 0 _tJournal of clinical pharmacology
_gvol. 40
_gno. 1
_gp. 74-83
856 4 0 _uhttps://doi.org/10.1177/00912700022008595
_zAvailable from publisher's website
999 _c10587077
_d10587077